- Home
- BDRX vs AKAN Comparison
BDRX vs AKAN Comparison
Compare BDRX & AKAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BDRX | AKAN |
|---|---|---|
| Founded | 2000 | 2021 |
| Country | United Kingdom | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8M | 2.0M |
| IPO Year | 2015 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BDRX | AKAN |
|---|---|---|
| Price | $0.95 | $0.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 163.1K | 109.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.79 | $0.42 |
| 52 Week High | $11.88 | $9.29 |
Technical Indicators
Market Signals| Indicator | BDRX | AKAN |
|---|---|---|
| Relative Strength Index (RSI) | 27.90 | 46.24 |
| Support Level | $0.79 | $0.82 |
| Resistance Level | $1.29 | $1.48 |
| Average True Range (ATR) | 0.13 | 0.11 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 0.02 | 38.78 |
Price Performance
Historical ComparisonAbout BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About AKAN Akanda Corp.
Akanda Corp is a cannabis cultivation, manufacturing, and distribution company. The company has three reportable segments: Cultivation, Distribution, and Corporate. A majority of its revenue is generated from the Distribution segment, which relates to the distribution of medical cannabis products, including cannabis oil and cannabis flower for medical use in the United Kingdom.